|
Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report.
This report is published in Value in Health. The citation for this report is:
Garrison Jr. LP, Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report. Value Health 2007;10:326-35.
Members’ Comments on
Draft Report
Task Force Co-Chairs:
Peter Neumann ScD, Professor, Tufts University School of Medicine Director,
Center for the Evaluation of Value and Risk in Health Institute for
Clinical Research and Health Policy Studies
and
Lou Garrison PhD,
University of Washington, Dept. of Pharmacy.
Task Force Working Groups
CLINICAL OUTCOMES
WORKING GROUP
Chair: Deborah Marshall PhD,
Vice President, Global Health Economics and Outcomes, i3 Innovus,
Burlington, ON, Canada
-
Marc Berger MD, Merck & Company Inc.,
West Point, PA, USA
-
Gurvaneet Randhawa MD, MPH, Center for
Outcomes and Evidence (COE), Agency for Healthcare Research and
Quality, Rockville, MD, USA
-
Bruce Carleton PhD, Pharmaceutical
Outcomes Programme, Children's and Women's Health Centre of British
Columbia, Vancouver, BC, Canada
-
Anne Smith, Pharmaceutical Outcomes
Programme, Children's and Women's Health Centre of British Columbia,
Vancouver, BC, Canada
ECONOMIC OUTCOMES
WORKING GROUP
Chair: Lou Garrison PhD,
Pharmaceutical Outcomes Research & Policy Program,
Department of Pharmacy, University of Washington, Seattle, WA, USA
-
Jens Grueger PhD, Novartis Pharmaceuticals AG, Basel,
Switzerland
- Penny Mohr,
US Center for Medicare and Medicaid Services, Baltimore, MD, USA
- Les Noe RPh,Ovation Research Group, Highland Park, IL, USA
- Bill Crown, i3 Innovus, Auburndale, MA, USA
PATIENT REPORTED OUTCOMES
WORKING GROUP
Chair: Penny
Erickson PhD,
O.L.G.A. , State College, PA, USA
-
Jamie Banks PhD,
Abt Associates, Lexington, MA, USA
-
Richard Chapman
PhD, ValueMedics Research, Alexandria, VA, USA
-
Mary A. Cifaldi,
Ph.D, RPh., MSHA, Abbott Laboratories, Abbott
Park, IL, USA
-
Andreas Pleil PhD, Pfizer Inc., San Diego, CA, USA
EVIDENCE HIERARCHIES
WORKING GROUP
Chair: Dan Mullins PhD, University
of Maryland, School of Pharmacy, Baltimore, MD, USA
-
Joe Jackson PhD, Bristol-Myers Squibb, Princeton, NJ, USA
-
Phil Sarocco MSc, RPh, Boston Scientific, Natick, MA, USA
-
Jennifer Elson-Lafata
PhD, Henry Ford Center for Health Services Research, Henry Ford
Health System, Detroit, MI, USA
|
